These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3949369)

  • 1. Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer.
    Bakouche O; Gerlier D
    Immunology; 1986 Feb; 57(2):219-23. PubMed ID: 3949369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of immunogenicity by antigen presentation in liposomes made from dimyristoylphosphatidylethanolamine linked to the secretion of prostaglandins by macrophages.
    Bakouche Q; David F; Gerlier D
    Eur J Immunol; 1987 Dec; 17(12):1839-42. PubMed ID: 3691627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of antibody response to liposome-associated Gross-virus cell-surface antigen (GCSAa).
    Gerlier D; Sakai F; Doré JF
    Br J Cancer; 1980 Feb; 41(2):236-42. PubMed ID: 7370163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.
    Bakouche O; Gerlier D
    Immunology; 1986 Jul; 58(3):507-13. PubMed ID: 3733150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of gross virus-associated cell-surface antigen with liposomes.
    Sakai F; Gerlier D; Doré JF
    Br J Cancer; 1980 Feb; 41(2):227-35. PubMed ID: 7370162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of Gross cell-surface antigen and p30 level in murine retrovirus-infected cell lines.
    Gerlier D; Gisselbrecht S; Guillemain B; Doré JF
    Br J Cancer; 1981 May; 43(5):659-68. PubMed ID: 7248150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 8. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cellular immune response to measles viral glycoproteins: role of the antigen vector.
    Bakouche O; Mougin B; Gerlier D
    Immunology; 1987 Dec; 62(4):605-11. PubMed ID: 3428926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major and minor Kb-restricted epitopes encoded by the endogenous ecotropic murine leukemia virus AKR623 that are recognized by anti-AKR/Gross MuLV CTL.
    White HD; Roeder DA; Lam T; Green WR
    Viral Immunol; 1994; 7(2):51-9. PubMed ID: 7848510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response elicited in rats by measles viral membrane antigens presented in liposomes and ISCOMs.
    Mougin B; Bakouche O; Gerlier D
    Vaccine; 1988 Oct; 6(5):445-9. PubMed ID: 3195201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inclusion of Gross virus cell surface associated antigen in liposomes].
    Gerlier D; Sakai F; Doré JF
    C R Acad Hebd Seances Acad Sci D; 1978 Feb; 286(5):439-42. PubMed ID: 418905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes.
    Raphael L; Tom BH
    Clin Exp Immunol; 1984 Jan; 55(1):1-13. PubMed ID: 6607141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine leukemia virus-associated cell surface antigens in rats neonatally infected with Gross murine leukemia virus.
    Basch RS; Grausz D; Harris N; Mitchison NA
    J Natl Cancer Inst; 1979 Dec; 63(6):1485-92. PubMed ID: 292817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on a gross-virus-induced lymphoma in the rat. III. Optimisation, specificity and applications of the in vitro immune response.
    Bruce J; Mitchison NA; Shellam GR
    Int J Cancer; 1976 Mar; 17(3):342-50. PubMed ID: 1254357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on a gross-virus-induced lymphoma in the rat. II. The role of cell-membrane-associated and serum P30 antigen in the antibody and cell-mediated response.
    Knight RA; Mitchison NA; Shellam GR
    Int J Cancer; 1975 Mar; 15(3):417-28. PubMed ID: 1140861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.